EOS imaging and Fosun Pharmaceutical AG enter into an agreement for a significant equity investment
EOS imaging today announced that it entered into a binding agreement with Fosun Pharmaceutical AG, an indirect subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma, stock code: 600196.SH, 02196.HK), related to an equity investment to be made by Fosun Pharmaceutical AG through an issuance of EOS imaging news shares.
EOS imaging announces First Half 2018 Sales of €17.5 Million supported by strong growth in Asia-Pacific and North America
EOS imaging today announced its non-audited consolidated sales revenue for the six months ended June 30, 2018
University Hospital Center of Grenoble Alpes (CHUGA) becomes the 20th University Hospital equipped with the EOS® system in France
The equipment will be dedicated to pediatric and adult care and to the development of innovative orthopedic treatments
EOS imaging announces first private practice installation of an EOS® system in Germany
ATOS Klinik Heidelberg’s specialized spine center, Zentrum für Wirbelsäulenchirurgie, adopts EOS® low-dose, 2D/3D full-body imaging system
EOS imaging Launches New EOSone Private Practice Program
Program Launched at Becker’s 16th Annual Future of Spine + The Spine, Orthopedic and Pain Management-Driven ASC Conference
EOS imaging Announces US FDA Clearance for hipEOS 3.0 Software
EOS imaging announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its hipEOS 3.0 surgical planning software.
EOS imaging announces 15th installation in Australia
The Queensland X-Ray practice in Gold Coast Private Hospital marks the 13th installation in a private facility in Australia
EOS imaging announces new EOS® system installations in two U.S. private orthopedic practices
EOS imaging announced that University Orthopedics in Providence, Rhode Island, and the Hey Clinic for Scoliosis and Spine Surgery in Raleigh, NC, have installed the EOS® system for low-dose, 2D and 3D imaging of patients.
EOS imaging reports 1st quarter 2018 revenue growth of 34% and full year 2017 results
EOS imaging today announces its first quarter 2018 consolidated sales revenue and consolidated results for the full year ended December 31, 2017, as adopted by the Board of Directors on April 11, 2018
EOS imaging previews stereoVIEW for comprehensive multidisciplinary clinical collaboration and patient engagement
EOS imaging will be showcasing stereoVIEW, hipEOS 3.0 (FDA Pending), and the rest of EOSapps at the 2018 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting
EOS imaging announces first system installation within Asklepios Private Hospital Group in Germany
The second largest private hospital group in Germany adopts EOS® for its Asklepios Paulinen Hospital
EOS imaging announces new installation in a top-ranking specialty orthopedic hospital in China
Beijing Jishuitan Hospital adopts the EOS® low dose, 2D/3D orthopedic imaging system